In this study, we investigated the prevalence and clinicopathological implications, including survival, of fascin immunoreactivity in either primary tumours or lymph node metastases of 228 patients with stage III–IV colonic adenocarcinoma. The gene discussed is FSCN1; the disease is colon adenocarcinoma.